Guggenheim Maintains Buy on BrightSpring Health, Raises Price Target to $84
Benzinga Newsdesk 10 hours ago
Analyst RatingsNewsPrice Target
Guggenheim analyst Jason Cassorla maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.
Guggenheim analyst Jason Cassorla maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.